💨 Abstract

Illumina Inc., a San Diego-based genetic testing tools company, reported first-quarter net income of $131 million, or 82 cents per share. Adjusted earnings were 97 cents per share, surpassing Wall Street's 96 cents per share estimate. Revenue was $1.04 billion, meeting forecasts. The company anticipates full-year earnings between $4.20 and $4.30 per share.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖